/

Other

/

Mitsubishi Tanabe Pharma Development America

Mitsubishi Tanabe Pharma Development America

Mitsubishi Tanabe Pharma Development America

Verified Nov 2026

Other

·

United States flag

Jersey City, New Jersey

·

Since 2016

Mitsubishi Tanabe Pharma Development America, headquartered in Jersey City, New Jersey and founded in 2016, is a subsidiary of Tanabe Pharma Corporation with 200–500 employees and estimated annual revenue between $1–5 billion. The company develops and commercializes pharmaceutical products for North American markets, focusing on serious and rare diseases including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes. It markets RADICAVA (edaravone) for ALS treatment.

Mitsubishi Tanabe Pharma Development America

Verified Nov 2026

AT A GLANCE

Founded

2016

Headquarters

United States flag

Jersey City, New Jersey

Employees

200-500

Ownership

Mitsubishi Tanabe Pharma Development America at a glance

Revenue

$1-5B

Est. band

Employees

200-500

Founded

2016

Headquarters

Jersey City, New Jersey

Industries

Automotive

Electric Vehicles

Medical

Overview

Mitsubishi Tanabe Pharma Development America, headquartered in Jersey City, New Jersey and founded in 2016, is a subsidiary of Tanabe Pharma Corporation with 200–500 employees and estimated annual revenue between $1–5 billion. The company develops and commercializes pharmaceutical products for North American markets, focusing on serious and rare diseases including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes. It markets RADICAVA (edaravone) for ALS treatment.

At a glance

Attribute

Detail

Founded

2016

Headquarters

Jersey City, New Jersey

Employees

200-500

Revenue

$1-5B (estimated)

What Mitsubishi Tanabe Pharma Development America makes

The company specializes in commercializing approved pharmaceuticals for therapeutic areas including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes mellitus.

Products and capabilities described on the company's own site include Pump (source: tanabe-pharma.com).

Latest developments

Company details

Tanabe Pharma America is a subsidiary of the Japan-based Tanabe Pharma Corporation and serves the North American healthcare market with focus on rare disease treatments. Mitsubishi Tanabe Pharma Development America was founded in 2016, has an estimated 200-500 employees, and is headquartered in Jersey City, New Jersey.

Frequently asked questions

What does Mitsubishi Tanabe Pharma Development America do?

Mitsubishi Tanabe Pharma Development America, headquartered in Jersey City, New Jersey and founded in 2016, is a subsidiary of Tanabe Pharma Corporation with 200–500 employees and estimated annual revenue between $1–5 billion. The company develops and commercializes pharmaceutical products for North American markets, focusing on serious and rare diseases including amyotrophic lateral sclerosis, multiple sclerosis, and diabetes. It markets RADICAVA (edaravone) for ALS treatment.

Where is Mitsubishi Tanabe Pharma Development America headquartered?

Mitsubishi Tanabe Pharma Development America is headquartered in Jersey City, New Jersey (525 Washington Boulevard, Jersey City, New Jersey, 07310).

When was Mitsubishi Tanabe Pharma Development America founded?

Mitsubishi Tanabe Pharma Development America was founded in 2016.

How big is Mitsubishi Tanabe Pharma Development America?

Mitsubishi Tanabe Pharma Development America has an estimated 200-500 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Jersey City, New Jersey (HQ)Headquarters · United States
Jersey City, New Jersey (HQ)525 Washington Boulevard, Jersey City, New Jersey, 07310, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.